UTILISATION IN VIVO DE CHONDROÏTINASE ET/OU D'HYALURONIDASE POUR AMÉLIORER L'ADMINISTRATION D'UN AGENT

• 收藏
• 分享

专利权人:

Inovio Pharmaceuticals; Inc.

发明人:

SMITH, Trevor,SCHOMMER, Nina,BRODERICK, Kate,YUNG, Bryan,SCHULTHEIS, Katherine

申请号：

EP17790648

公开号：

EP3448993A4

申请日:

2017.05.01

申请国别(地区):

EP

年份:

2020

代理人:

摘要：

Disclosed herein are methods of delivering an agent to a subject. Further disclosed herein are methods of treating a disease or disorder in a subject. The methods may include administering to the subject a chondroitinase polypeptide or a polynucleotide encoding a chondroitinase polypeptide in an amount sufficient to degrade glycosaminoglycans, and administering to the subject the agent. The methods may further include administering a hyaluronidase polypeptide or a polynucleotide encoding a hyaluronidase.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/